Alcon AG reported $2.58B in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
AstraZeneca USD 14.46B 867M Jun/2025
Bayer EUR 10.74B 3B Jun/2025
Essilor EUR 14.02B 7.17B Jun/2025
Fresenius EUR 5.58B 70M Jun/2025
Fresenius Medical Care EUR 4.79B 90M Jun/2025
GlaxoSmithKline GBP 7.99B 470M Jun/2025
GRIFOLS EUR 1.89B 100M Jun/2025
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 4.43B 850M Jun/2025
Novartis USD 14.05B 821M Jun/2025
Philips EUR 4.34B 241M Jun/2025
Roche Holding CHF 31.64B 883M Dec/2024
Sanofi EUR 9.99B 90M Jun/2025
Smith & Nephew USD 1.55B 140M Jun/2025
Sonova Holding CHF 1.83B 40.7M Sep/2024
UCB EUR 3.49B 129M Jun/2025